Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...

Eli Lilly, BCE, Suncor, Canada Goose ... proceeded to steer the rail and commercial aviation giant through the COVID-19 pandemic and streamline it into a pure-play business jet outfit.

The US government said it will buy 300,000 doses of Eli Lilly’s COVID-19 therapy bamlanivimab for $375 million if the drug gets Emergency Use Authorisation (EUA) – although its effectiveness ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

Jim Cramer, the host of Mad Money, recently took a deep dive into the challenges facing the consumer packaged goods sector, ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... and experimental drugs for COVID-19. “The bottom line: Ask yourself what happens if things get better ...

Here are the most important news items that investors need to start their trading day: ...

Indiana's workforce is feeling pressure to return to the office, but a good portion of employees still like hybrid work. Is ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

Al-Aly and his research group have gained notoriety with their findings on long COVID and for establishing ... and heart and kidney diseases. Eli Lilly, after tirzepatide's late-stage cardio ...

Eli Lilly and Company discovers ... severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis ...

This week was loaded with earnings releases of many large drugmakers. Novo Nordisk NVO, Merck MRK, Pfizer PFE, Eli Lilly LLY, ...